Connexin and Pannexin Hemichannel Signaling in Neurodegeneration

Connexin and Pannexin Hemichannel Signaling in Neurodegeneration

Overview

Connexins and pannexins are transmembrane channel proteins that form gap junctions and hemichannels, allowing direct communication between cells and between the intracellular and extracellular compartments. In the central nervous system, these channels play critical roles in neuronal function, glial signaling, and neuroimmune interactions. Dysregulation of connexin and pannexin signaling has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and stroke. This pathway page explores the molecular mechanisms by which these channels contribute to neurodegeneration and their potential as therapeutic targets.

Connexin and Pannexin Family

Connexins

Connexins are a family of 21 members in humans, named by their molecular weight (e.g., Cx26 = 26 kDa). Key connexins in the CNS include: [@orellana2020]

Connexin and Pannexin Hemichannel Signaling in Neurodegeneration

Overview

Connexins and pannexins are transmembrane channel proteins that form gap junctions and hemichannels, allowing direct communication between cells and between the intracellular and extracellular compartments. In the central nervous system, these channels play critical roles in neuronal function, glial signaling, and neuroimmune interactions. Dysregulation of connexin and pannexin signaling has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and stroke. This pathway page explores the molecular mechanisms by which these channels contribute to neurodegeneration and their potential as therapeutic targets.

Connexin and Pannexin Family

Connexins

Connexins are a family of 21 members in humans, named by their molecular weight (e.g., Cx26 = 26 kDa). Key connexins in the CNS include: [@orellana2020]

| Connexin | Gene | Primary CNS Expression | Functions | [@froger2022]
|----------|------|----------------------|-----------| [@kimelberg2021]
| Cx36 | GJC2 | Neurons (retinal amacrine, interneurons) | Electrical synapses | [@kelley2023]
| Cx43 | GJA1 | Astrocytes, ependymal cells | Metabolic coupling, calcium waves | [@fasciani2020]
| Cx30 | GJB6 | Astrocytes | Potassium buffering, BBB function | [@abudara2019]
| Cx26 | GJB2 | Oligodendrocytes, astrocytes | Myelin maintenance | [@bennett2020]
| Cx32 | GJB1 | Oligodendrocytes, Schwann cells | Myelin sheath function | [@sanchezarias2022]
| Cx45 | GJA7 | Neurons, astrocytes | Synaptic transmission | [@giaume2021]

Pannexins

Pannexins (PANX1, PANX2, PANX3) are a distinct family of channel proteins that primarily form single-membrane hemichannels rather than gap junction channels:

• PANX1: Ubiquitously expressed, forms large-pore hemichannels (~500 Da cutoff)
• PANX2: Primarily neuronal expression, forms smaller channels
• PANX3: Expressed in skin, cartilage, and some glial cells

Channel Physiology

Gap Junction Channels

Gap junctions direct cell-to-cell communication by connecting the cytoplasm of adjacent cells:

Hemichannels

Unpaired hemichannels allow communication between intracellular and extracellular compartments:

• Release of signaling molecules: ATP, glutamate, NAD+, prostaglandins
• uptake of nutrients and ions: Calcium, sodium, potassium
• Activation by: mechanical stress, depolarization, intracellular calcium

Signaling Mechanisms in Neurodegeneration

ATP Release and Purinergic Signaling

Glutamate Excitotoxicity

• Hemichannel opening allows glutamate release into extracellular space
• Activation of NMDA and AMPA receptors leads to calcium overload
• Excessive calcium influx triggers apoptotic pathways
• Particularly relevant in ALS and stroke

Neuroinflammation

• PANX1 hemichannel opening activates P2X7 receptors on microglia
• NLRP3 inflammasome activation and IL-1β release
• Propagation of inflammatory signals between astrocytes
• Chronic neuroinflammation drives disease progression

Roles in Specific Neurodegenerative Diseases

Alzheimer's Disease

• Aβ interaction: Amyloid-β peptide directly interacts with Cx43 hemichannels
• Calcium dysregulation: Aβ-induced hemichannel opening contributes to calcium overload
• ATP release: Enhanced extracellular ATP via hemichannels activates microglia
• Astrocyte dysfunction: Cx43 gap junction communication impaired in AD brain
• Therapeutic implications: Blocking hemichannel opening reduces Aβ toxicity in models

Parkinson's Disease

• Dopaminergic neuron vulnerability: Cx36 gap junctions between dopaminergic neurons
• α-Synuclein effects: α-Synuclein oligomers alter hemichannel function
• Microglial activation: PANX1 opening in response to α-syn leads to inflammation
• Therapeutic targeting: Hemichannel blockers show neuroprotection in PD models

Amyotrophic Lateral Sclerosis

• Motor neuron excitability: Altered Cx36 expression in motor neurons
• Astrocyte dysfunction: Loss of Cx43 gap junction coupling in ALS astrocytes
• glutamate transport: Hemichannel dysfunction affects glutamate clearance
• Microglial P2X7: Enhanced PANX1/P2X7 signaling in ALS microglia

Stroke and Brain Injury

• Ischemic cascade: ATP release via hemichannels triggers excitotoxicity
• Inflammatory response: PANX1 opening in astrocytes and microglia
• Blood-brain barrier: Cx43 hemichannels on endothelial cells
• Neuroprotection: Hemichannel blockers reduce infarct size in animal models

Therapeutic Targeting

Hemichannel Blockers

| Compound | Target | Development Stage | Evidence |
|----------|--------|-----------------|----------|
| Carbenoxolone | Cx hemichannels | Preclinical | Blocks ATP release, neuroprotective in stroke models |
| Octanol | Cx36 gap junctions | Preclinical | Reduces seizure activity |
| Gap26 | Cx43 mimetic peptide | Preclinical | Reduces infarct size, improves functional outcome |
| BBG (Brilliant Blue G) | P2X7 receptor | Preclinical | Blocks PANX1 downstream effects |
| Probenecid | PANX1 | Approved (gout) | Blocks PANX1 currents |

Mechanism-Based Strategies

• Peptide mimetics: Gap26, Gap27 (connexin mimetic peptides)
• Antibody approaches: Anti-PANX1 antibodies under development
• Small molecule inhibitors: Modified carbenoxolone derivatives with improved BBB penetration
• Gene therapy: Targeting connexin expression

Research Gaps and Future Directions

See Also

• Gap Junction Communication
• [Astrocytes in Neurodegeneration](/cell-types/astrocytes)
• [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
• [Ion Channel Dysfunction](/mechanisms/ion-channel-dysfunction)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [Connexin Hemichannels - Wikipedia](https://en.wikipedia.org/wiki/Connexin)
• [Pannexin Channels - Wikipedia](https://en.wikipedia.org/wiki/Pannexin)
• [UniProt: GJA1 (Connexin 43)](https://www.uniprot.org/uniprot/P17302)
• [UniProt: GJB2 (Connexin 26)](https://www.uniprot.org/uniprot/P29033)
• [NCBI Gene: GJA1](https://www.ncbi.nlm.nih.gov/gene/2697)
• [NCBI Gene: PANX1](https://www.ncbi.nlm.nih.gov/gene/24145)

Recent Research Updates (2024-2026)

• [G et al. 2025: A High-Fidelity RNA-Targeting Cas13X Downregulates Connexin43 in Macro](https://pubmed.ncbi.nlm.nih.gov/40536333/)
• [JC et al. 2025: Connexin and Pannexin Hemichannels: Broad-Spectrum Players in Neuroinf](https://pubmed.ncbi.nlm.nih.gov/40956013/)
• [E et al. 2025: Long-term editing of brain circuits in mice using an engineered electr](https://pubmed.ncbi.nlm.nih.gov/40196531/)
• [Y et al. 2026: Inhibition of connexin hemichannels protects retinal ganglion cells ag](https://pubmed.ncbi.nlm.nih.gov/41545794/)
• [S et al. 2025: Mechanistic insights into connexin-mediated neuroglia crosstalk in neu](https://pubmed.ncbi.nlm.nih.gov/40007760/)

References